Decoding the transcriptome
A structurally enabled drug discovery platform driving insights into RNA modification biology
Scaffold Therapeutics is advancing a unique pipeline of assets targeting clinically validated and first in class biology in oncology, neurodegeneration and other therapeutic areas
Our research is focused on regulating modifications of RNA that control its stability, transcription and degradation.
Target | Indication | Discovery | IND Enabling | Clinical |
METTL3 | Solid Tumors Neurodegeneration |
|||
YTHDC1 | Solid Tumors | |||
Undisclosed | Rare Neuro |
Please contact bd@scaffoldtx.com for information on partnering.